PMID: 6111723Dec 22, 1980Paper

Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol

Life Sciences
H C ChengJ K Woodward


No abstract listed.


Jan 1, 1990·European Journal of Clinical Pharmacology·W KrauseN Sauerbrey
Jan 1, 1984·European Journal of Clinical Pharmacology·E J Ariëns
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·A A Hancock
Mar 1, 1984·Journal of Autonomic Pharmacology·H C Cheng, J K Woodward
Jul 1, 1984·Medicinal Research Reviews·M Simonyi
May 1, 1984·British Journal of Clinical Pharmacology·H L ElliottJ L Reid
Apr 1, 1988·Medicinal Research Reviews·E J Ariëns
Oct 1, 1983·Biopharmaceutics & Drug Disposition·F J KeeleyR A Okerholm
Mar 1, 1982·The Journal of Pharmacy and Pharmacology·J K Woodward, H C Cheng
Oct 1, 1983·Journal of Clinical Pharmacology·N D VlachakisR F Maronde

Related Concepts

Medroxalol monohydrochloride, (S-(R*, S*))-isomer
Adrenergic alpha-Antagonists
Adrenergic beta-Antagonists
Antihypertensive Agents
Ascending Aorta Structure
Diastolic Blood Pressure
Dose-Response Relationship, Drug
Cavia porcellus

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.